[1]刘源源.左乙拉西坦治疗成人癫痫疗效及对患者血清脑源性神经营养因子和miR-134-5p的影响[J].陕西医学杂志,2021,50(3):349-352.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.024]
　LIU Yuanyuan.Efficacy of levetiracetam in treatment of adult epilepsy and its effect on serum BDNF and miR-134-5p[J].,2021,50(3):349-352.[doi:DOI:10.3969/j.issn.1000-7377.2021.03.024]
点击复制

左乙拉西坦治疗成人癫痫疗效及对患者血清脑源性神经营养因子和miR-134-5p的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年3期
页码:
349-352
栏目:
药物与临床
出版日期:
2021-03-01

文章信息/Info

Title:
Efficacy of levetiracetam in treatment of adult epilepsy and its effect on serum BDNF and miR-134-5p
作者:
刘源源
(辽阳市中心医院神经内科,辽宁 辽阳 111000)
Author(s):
LIU Yuanyuan
(Department of Neurology,Liaoyang Central Hospital,Liaoyang 111000,China)
关键词:
癫痫;  左乙拉西坦;  脑源性神经营养因子;  miR-134-5p;  焦虑;  抑郁;  不良反应
Keywords:
Epilepsy;  Levetiracetam;  BDNF;  MiR-134-5p;  Anxiety;  Depression;  Adverse reaction
分类号:
R 742.1
DOI:
DOI:10.3969/j.issn.1000-7377.2021.03.024
文献标志码:
A
摘要:
目的:观察左乙拉西坦对成人癫痫患者的治疗作用,分析其对患者血清中脑源性神经营养因子(BDNF)和微小RNA-134-5p(miR-134-5p)表达水平的影响。方法:选择126例癫痫患者,按入院顺序单双号分为观察组和对照组,各63例。观察组应用乙拉西坦进行治疗,对照组应用丙戊酸钠进行治疗,共治疗12个月。应用焦虑自评量表(SAS)、抑郁自评量表(SDS)评估两组患者治疗后焦虑和抑郁评分并进行比较。应用酶联免疫吸附实验检测血清中BDNF的表达水平并进行比较。应用实时荧光定量PCR法检测血清中miR-134-5p的表达水平并进行比较。结果:两组患者治疗总有效率比较无统计学差异(P>0.05)。两组中局灶性发作患者和全面性发作患者治疗总有效率比较均无统计学差异(均P>0.05)。观察组治疗后SAS、SDS评分均明显低于对照组(均P<0.05)。观察组治疗后血清中BDNF的表达水平明显高于对照组,miR-134-5p的表达水平明显低于对照组(均P<0.05)。两组患者不良反应发生情况比较无统计学差异(P>0.05)。结论:左乙拉西坦对成人癫痫有较好的治疗效果,与丙戊酸钠有类似的作用。左乙拉西坦还能改善患者负性情绪,有效优化血清中BDNF和miR-134-5p的表达水平。
Abstract:
Objective:To observe the therapeutic effect of levetiracetam in the treatment of adult epilepsy,and analyze its effect on the expression of serum brain-derived neurotrophic factor(BDNF)and microRNA-134-5p(miR-134-5p)in patients.Methods:126 patients with adult epilepsy were divided into observation group(63 cases)and control group(63 cases).The control group was treated with valproate sodium,and the observation group was treated with levetiracetam for 12 months.Anxiety was analyzed by SAS,and depression was analyze by SDS after treatment,and the scores of SAS and SDS were compared between the two groups.BDNF was detected by ELISA,and miR-134-5p was detected by real-time PCR after treatment,and the levels of BDNF and miR-134-5p were compared between the two groups.Results:There was no statistical difference in the total effective rate of treatment between the two groups and(P>0.05).There was no significant difference in the total effective rate of treatment in patients with focal seizures and patients with generalized seizures between the two groups(all P>0.05).The SAS and SDS scores of the observation group after treatment were significantly lower than those of the control group(all P<0.05).After treatment,the expression level of BDNF in the serum of the observation group was significantly higher than that of the control group,and the expression level of miR-134-5p was significantly lower than that of the control group(all P<0.05).There was no statistical difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Levetiracetam is effective on adult epilepsy,similar to valproate sodium.Levetiracetam can also improve the negative emotions of patients,optimize the expression levels of BDNF and miR-134-5p.

参考文献/References:

[1] 侯小兵,苏绮璇.多维度综合评估新型抗癫痫药物对癫痫病人认知功能的影响[J].中西医结合心脑血管病杂志,2019,17(9):1410-1413.
[2] 贾东佩,李春雷.穴位埋线治疗难治性癫痫疗效及对血清GAL、PGP、MBP的影响[J].陕西中医,2019,40(4):528-530.
[3] 万雅迪,张艳华,王 玉.中脑导水管周围灰质脑源性神经营养因子高表达对癫痫发作的影响[J].临床神经病学杂志,2018,31(4):41-44.
[4] 王晓爽,国 琦,朱亚飞,等.癫痫患者外周血miR-134表达及意义[J].中风与神经疾病杂志,2020,37(2):154-157.
[5] Heller HB.Feline epilepsy[J].Vet Clin North Am Small Anim Pract,2018,48(1):31-43.
[6] 史剑飞,卢北玲,宁远征.儿童癫痫患者血清胱抑素C表达水平及检测意义[J].陕西医学杂志,2019,48(10):144-147.
[7] 温飞飞.左乙拉西坦治疗癫痫的疗效及对患者BDNF、CRP水平和认知功能的影响[J].实验与检验医学,2018,36(6):953-955.
[8] 王 娟,费世早,张 玥,等.抑制miR-134表达对幼鼠颞叶癫痫海马神经元的保护作用及其机制[J].中国神经免疫学和神经病学杂志,2020,27(5):378-380.
[9] 张 双,庞保东,金 超,等.左乙拉西坦对癫痫患儿骨代谢影响的临床观察[J].中国医院药学杂志,2012,32(17):1379-1381.
[10] 刘 伟,蔡兴秋.左乙拉西坦单药或添加治疗癫痫的临床观察[J].临床神经病学杂志,2012,25(3):227-229.
[11] Howard P,Remi J,Remi C,et al.Levetiraceta[J].J Pain Symptom Manage,2018,56(4):645-649.
[12] Grinspan ZM,Shellhaas RA,Coryell J,et al.Comparative effectiveness of levetiracetam vs phenobarbital for infantile epilepsy[J].JAMA Pediatr,2018,172(4):352-360.
[13] Lyseng-Williamson KA.Levetiracetam:A review of its use in epilepsy[J].Drugs,2011,71(4):489-514.
[14] Akter N,Rahman MM,Akhter S,et al.A randomized controlled trial of phenobarbital and levetiracetam in childhood epilepsy[J].Mymensingh Med J,2018,27(4):776-784.
[15] Arican P,Gencpinar P,Cavusoglu D,et al.Levetiracetam monotherapy for the treatment of infants with epilepsy[J].Seizure,2018,56(1):73-77.
[16] 帕力达?克立木,阿帕尔?卡哈尔,白婷迪娜,等.左乙拉西坦片对老年癫痫患者相关血清指标及疗效的影响[J].西部医学,2018,30(6):864-867.
[17] 张军武,李培育.癫痫复杂部分性发作患者认知功能与磁共振波谱及血清BDNF、IGF-1水平的相关性分析[J].检验医学与临床,2018,2(15):99-101.
[18] 范 剑,刘 强.醋酸艾司利卡西平对癫痫患者炎症因子、脑源性神经营养因子水平的影响[J].实用医院临床杂志,2019,24(5):12-14.

相似文献/References:

[1]史剑飞,卢北玲,宁远征△.儿童癫痫患者血清胱抑素C表达水平及检测意义*[J].陕西医学杂志,2019,(10):1393.
[2]张亚琼,姬冬林.奥扎格雷钠对癫痫小鼠应激、神经损伤程度和神经功能重建相关因子及凝血指标的影响[J].陕西医学杂志,2022,51(7):787.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.004]
　ZHANG Yaqiong,JI Donglin.Effects of sodium ozagrel on stress,nerve injury degree,neural function reconstruction related factors and coagulation indexes in epilepsy mice[J].,2022,51(3):787.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.004]
[3]杨 谦,曹冰清,韩 征,等.CXC趋化因子配体10在癫痫大鼠和细胞炎症反应中的作用及机制研究[J].陕西医学杂志,2022,51(12):1483.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.004]
　YANG Qian,CAO Bingqing,HAN Zheng,et al.Role and mechanism of CXC chemokine ligand-10 in inflammatory response of epileptic rats and cells[J].,2022,51(3):1483.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.004]
[4]曹志伟,张润春,王玉珍,等.癫痫患儿血清胱抑素C、脂蛋白相关磷脂酶A2水平与拉考沙胺添加治疗反应性关系及其预测价值[J].陕西医学杂志,2024,(3):372.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.018]
[5]于 乐,王 沛,姜梦真.癫痫患儿血清基质金属蛋白酶-9、谷氨酸脱羧酶抗体、高迁移率族蛋白B1水平与左乙拉西坦治疗效果相关性及联合检测对治疗效果的预测价值[J].陕西医学杂志,2025,54(3):374.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.017]
　YU Le,WANG Pei,JIANG Mengzhen.Correlation of serum MMP-9,GADA,HMGB1 levels with therapeutic effect of levetiracetam in children with epilepsy,and predictive value of combined detection for therapeutic effect[J].,2025,54(3):374.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.017]

更新日期/Last Update: 2021-03-04